AI assistant
Sending…
HERON THERAPEUTICS, INC. /DE/ — Director's Dealing 2012
Sep 24, 2012
33572_dirs_2012-09-24_2de9e75e-601d-4b81-822b-69689c49e3ca.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: AP PHARMA INC /DE/ (APPA)
CIK: 0000818033
Period of Report: 2012-07-25
Reporting Person: SPCH, LLLP (10% Owner)
Reporting Person: Midler Andrew R (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock $0.010 par value | 36190476 | Direct |
| Common Stock $0.010 Par Value | 1904762 | Indirect |
More from HERON THERAPEUTICS, INC. /DE/
Regulatory Filings
2026
Jun 2
Major Shareholding Notification
2026
May 13
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Proxy Solicitation & Information Statement
2026
Apr 30
Regulatory Filings
2026
Apr 20
Board/Management Information
2026
Apr 6
Major Shareholding Notification
2026
Mar 27